<DOC>
	<DOC>NCT01798264</DOC>
	<brief_summary>evaluate the safety and tolerability of ITCA 650 in subjects with type 2 diabetes mellitus.</brief_summary>
	<brief_title>Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>type 2 diabetes &gt;6 months stable diet &amp; exercise, metformin, TZD or met + TZD HbA1c &gt;6.5% &lt;10.0% prior treatment with exenatide history of pancreatitis history of medullary thyroid cancer or multiple endocrine neoplasia 2</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>